Recorded fact · drug.label_indication
drug.label_indication for tirzepatide|obesity
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact a81e81f0 resolves to.
The record
| Fact id | a81e81f01c6183adbfb0b7a6 |
|---|---|
| Entity | drug: tirzepatide|obesity |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260828 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 71478e66838b7ae2a19e412edae76b0e40c6c8ebf327fbd9f3886edd1c8a2ebe.
The value
{
"ingredient": "Tirzepatide",
"conditionId": "obesity",
"conditionName": "Obesity",
"matchedAlias": "obesity",
"context": "indication",
"brand": "Zepbound",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "487cd7e7-434c-4925-99fa-aa80b1cc776b",
"labelEffectiveTime": "20260828",
"labelsRead": 8,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 36920abecf2f81ccecd86a0702f0656506550fd09d94f7c519c3933fa36e74b7.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.